VYGR · CIK 0001640266 · operating
Voyager Therapeutics, Inc. (VYGR) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $228 million, Voyager Therapeutics, Inc. is a micro-cap company. The stock currently trades at $4.15, up 1.22% today, with a 52-week range of $2.65–$5.55.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-1.13 | $-1.13 | -138.0% | |
| 2023 | $2.97 | $3.08 | +345.5% | |
| 2022 | $-1.21 | $-1.21 | +36.0% | |
| 2021 | $-1.89 | $-1.89 | -292.9% | |
| 2020 | $0.98 | $0.99 | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | — | — | — | |
| 2015 | — | — | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-11 | 0001558370-25-002703 | SEC ↗ |
| 2023-12-31 | 2024-02-28 | 0001558370-24-001988 | SEC ↗ |
| 2022-12-31 | 2023-03-07 | 0001558370-23-002989 | SEC ↗ |
| 2021-12-31 | 2022-03-08 | 0001558370-22-003015 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001558370-21-001865 | SEC ↗ |
| 2019-12-31 | 2020-03-03 | 0001558370-20-001974 | SEC ↗ |
| 2018-12-31 | 2019-02-26 | 0001558370-19-001105 | SEC ↗ |
| 2017-12-31 | 2018-03-14 | 0001558370-18-002038 | SEC ↗ |
| 2016-12-31 | 2017-03-15 | 0001558370-17-001797 | SEC ↗ |
| 2015-12-31 | 2016-03-17 | 0001558370-16-004222 | SEC ↗ |